The survival of CarCR patients in comparison to the expected survival of matched general populations and by subgroups of interest. (A) Comparison of survival in those patients with AL amyloidosis who achieved a CarCR vs their expected survival based on age-, sex-, and country-matched population estimates. (B) Survival of CarCR patients from the time of therapy (Tx) initiation, stratified by cardiac stage at diagnosis (P = .96 for comparison between CarCR in cardiac stage II and CarCR in cardiac stage III). (C) Survival of CarCR patients from the time of therapy initiation, stratified by best hematological response (P = .20 for comparison between CarCR in hematological CR [HemCR] and CarCR in nonhematological CR).